Tobi

In the US, Tobi (tobramycin systemic) is a member of the following drug classes: aminoglycosides, inhaled anti-infectives and is used to treat Bacteremia, Bacterial Infection, Bone infection, Burns - External, Cystic Fibrosis, Endocarditis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Meningitis, Peritonitis, Pneumonia, Rabbit Fever, Sepsis, Shunt Infection and Skin Infection.

US matches:

• Tobi Solution


• Tobi inhalation


• Tobi

UK matches:

• Tobi 300 mg/5 ml Nebuliser Solution (Novartis Pharmaceuticals UK Ltd) (SPC)

Ingredient matches for Tobi

Tobramycin

Tobramycin is reported as an ingredient of Tobi in the following countries:

• Argentina


• Austria


• Belgium


• Bulgaria


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hungary


• Ireland


• Israel


• Italy


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Norway


• Portugal


• Romania


• Slovakia


• South Africa


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

Tobramycin sulfate (a derivative of Tobramycin) is reported as an ingredient of Tobi in the following countries:

• Bangladesh


• Canada


• Poland

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.